Logo image of FRPT

FRESHPET INC (FRPT) Stock Fundamental Analysis

USA - NASDAQ:FRPT - US3580391056 - Common Stock

54.12 USD
-0.07 (-0.13%)
Last: 10/24/2025, 8:27:54 PM
54.5 USD
+0.38 (+0.7%)
After Hours: 10/24/2025, 8:27:54 PM
Fundamental Rating

5

Overall FRPT gets a fundamental rating of 5 out of 10. We evaluated FRPT against 86 industry peers in the Food Products industry. FRPT has an average financial health and profitability rating. FRPT shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

FRPT had positive earnings in the past year.
FRPT had a positive operating cash flow in the past year.
In the past 5 years FRPT reported 4 times negative net income.
Of the past 5 years FRPT 4 years had a positive operating cash flow.
FRPT Yearly Net Income VS EBIT VS OCF VS FCFFRPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M -200M -300M

1.2 Ratios

FRPT has a Return On Assets (2.04%) which is comparable to the rest of the industry.
FRPT has a Return On Equity (3.14%) which is in line with its industry peers.
FRPT's Return On Invested Capital of 2.84% is in line compared to the rest of the industry. FRPT outperforms 49.43% of its industry peers.
Industry RankSector Rank
ROA 2.04%
ROE 3.14%
ROIC 2.84%
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
FRPT Yearly ROA, ROE, ROICFRPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 -4

1.3 Margins

FRPT has a Profit Margin of 3.23%. This is in the better half of the industry: FRPT outperforms 63.22% of its industry peers.
With a decent Operating Margin value of 5.38%, FRPT is doing good in the industry, outperforming 60.92% of the companies in the same industry.
With an excellent Gross Margin value of 40.87%, FRPT belongs to the best of the industry, outperforming 94.25% of the companies in the same industry.
FRPT's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 5.38%
PM (TTM) 3.23%
GM 40.87%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
FRPT Yearly Profit, Operating, Gross MarginsFRPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

More info and screens

6

2. Health

2.1 Basic Checks

FRPT has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
FRPT has more shares outstanding than it did 1 year ago.
FRPT has more shares outstanding than it did 5 years ago.
The debt/assets ratio for FRPT has been reduced compared to a year ago.
FRPT Yearly Shares OutstandingFRPT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
FRPT Yearly Total Debt VS Total AssetsFRPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

An Altman-Z score of 3.50 indicates that FRPT is not in any danger for bankruptcy at the moment.
With a decent Altman-Z score value of 3.50, FRPT is doing good in the industry, outperforming 75.86% of the companies in the same industry.
A Debt/Equity ratio of 0.40 indicates that FRPT is not too dependend on debt financing.
FRPT has a Debt to Equity ratio (0.40) which is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Altman-Z 3.5
ROIC/WACC0.37
WACC7.73%
FRPT Yearly LT Debt VS Equity VS FCFFRPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 4.81 indicates that FRPT has no problem at all paying its short term obligations.
The Current ratio of FRPT (4.81) is better than 95.40% of its industry peers.
FRPT has a Quick Ratio of 3.75. This indicates that FRPT is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 3.75, FRPT belongs to the best of the industry, outperforming 95.40% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 4.81
Quick Ratio 3.75
FRPT Yearly Current Assets VS Current LiabilitesFRPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M

More info and screens

7

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 104.00% over the past year.
The Revenue has grown by 19.30% in the past year. This is quite good.
FRPT shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 31.72% yearly.
EPS 1Y (TTM)104%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1200%
Revenue 1Y (TTM)19.3%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%12.51%

3.2 Future

FRPT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.76% yearly.
FRPT is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.47% yearly.
EPS Next Y16.6%
EPS Next 2Y44.4%
EPS Next 3Y41.3%
EPS Next 5Y32.76%
Revenue Next Year13.52%
Revenue Next 2Y12.81%
Revenue Next 3Y12.35%
Revenue Next 5Y12.47%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
FRPT Yearly Revenue VS EstimatesFRPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 500M 1B 1.5B 2B 2.5B
FRPT Yearly EPS VS EstimatesFRPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2016 2018 2020 2022 2024 2026 2028 2030 2032 0 2 4 6 8

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 53.06, FRPT can be considered very expensive at the moment.
FRPT's Price/Earnings is on the same level as the industry average.
FRPT's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 26.89.
A Price/Forward Earnings ratio of 27.61 indicates a quite expensive valuation of FRPT.
The rest of the industry has a similar Price/Forward Earnings ratio as FRPT.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.99, FRPT is valued a bit more expensive.
Industry RankSector Rank
PE 53.06
Fwd PE 27.61
FRPT Price Earnings VS Forward Price EarningsFRPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40 50

4.2 Price Multiples

FRPT's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 20.33
FRPT Per share dataFRPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
FRPT's earnings are expected to grow with 41.30% in the coming years. This may justify a more expensive valuation.
PEG (NY)3.2
PEG (5Y)N/A
EPS Next 2Y44.4%
EPS Next 3Y41.3%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for FRPT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

FRESHPET INC

NASDAQ:FRPT (10/24/2025, 8:27:54 PM)

After market: 54.5 +0.38 (+0.7%)

54.12

-0.07 (-0.13%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)08-04 2025-08-04/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners119.43%
Inst Owner Change0.01%
Ins Owners1.68%
Ins Owner Change0.57%
Market Cap2.64B
Revenue(TTM)1.04B
Net Income(TTM)33.68M
Analysts80.87
Price Target93.66 (73.06%)
Short Float %15.26%
Short Ratio4.75
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)73.73%
Min EPS beat(2)-9.66%
Max EPS beat(2)157.12%
EPS beat(4)2
Avg EPS beat(4)64.83%
Min EPS beat(4)-9.66%
Max EPS beat(4)157.12%
EPS beat(8)6
Avg EPS beat(8)129.92%
EPS beat(12)8
Avg EPS beat(12)86.35%
EPS beat(16)8
Avg EPS beat(16)40.73%
Revenue beat(2)0
Avg Revenue beat(2)-1.97%
Min Revenue beat(2)-3.16%
Max Revenue beat(2)-0.78%
Revenue beat(4)1
Avg Revenue beat(4)-1.59%
Min Revenue beat(4)-3.16%
Max Revenue beat(4)0.07%
Revenue beat(8)4
Avg Revenue beat(8)-0.08%
Revenue beat(12)6
Avg Revenue beat(12)0.14%
Revenue beat(16)7
Avg Revenue beat(16)-0.61%
PT rev (1m)-1.74%
PT rev (3m)-12.87%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)2.3%
EPS NY rev (1m)-2.07%
EPS NY rev (3m)-12.8%
Revenue NQ rev (1m)-0.48%
Revenue NQ rev (3m)-2.37%
Revenue NY rev (1m)-0.35%
Revenue NY rev (3m)-1.82%
Valuation
Industry RankSector Rank
PE 53.06
Fwd PE 27.61
P/S 2.53
P/FCF N/A
P/OCF 18.19
P/B 2.46
P/tB 2.46
EV/EBITDA 20.33
EPS(TTM)1.02
EY1.88%
EPS(NY)1.96
Fwd EY3.62%
FCF(TTM)-0.14
FCFYN/A
OCF(TTM)2.98
OCFY5.5%
SpS21.4
BVpS21.97
TBVpS21.97
PEG (NY)3.2
PEG (5Y)N/A
Graham Number22.45
Profitability
Industry RankSector Rank
ROA 2.04%
ROE 3.14%
ROCE 3.6%
ROIC 2.84%
ROICexc 3.37%
ROICexgc 3.37%
OM 5.38%
PM (TTM) 3.23%
GM 40.87%
FCFM N/A
ROA(3y)-1.53%
ROA(5y)-1.83%
ROE(3y)-1.62%
ROE(5y)-1.96%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y0.84%
GM growth 5Y-2.62%
F-Score8
Asset Turnover0.63
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF N/A
Debt/EBITDA 3.06
Cap/Depr 184.01%
Cap/Sales 14.58%
Interest Coverage 6.25
Cash Conversion 104.51%
Profit Quality N/A
Current Ratio 4.81
Quick Ratio 3.75
Altman-Z 3.5
F-Score8
WACC7.73%
ROIC/WACC0.37
Cap/Depr(3y)442.82%
Cap/Depr(5y)604.48%
Cap/Sales(3y)29.67%
Cap/Sales(5y)41.38%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)104%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%1200%
EPS Next Y16.6%
EPS Next 2Y44.4%
EPS Next 3Y41.3%
EPS Next 5Y32.76%
Revenue 1Y (TTM)19.3%
Revenue growth 3Y31.84%
Revenue growth 5Y31.72%
Sales Q2Q%12.51%
Revenue Next Year13.52%
Revenue Next 2Y12.81%
Revenue Next 3Y12.35%
Revenue Next 5Y12.47%
EBIT growth 1Y247.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year389.58%
EBIT Next 3Y94.32%
EBIT Next 5Y59.23%
FCF growth 1Y96.77%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y666.43%
OCF growth 3Y519.17%
OCF growth 5Y56.72%

FRESHPET INC / FRPT FAQ

What is the ChartMill fundamental rating of FRESHPET INC (FRPT) stock?

ChartMill assigns a fundamental rating of 5 / 10 to FRPT.


What is the valuation status of FRESHPET INC (FRPT) stock?

ChartMill assigns a valuation rating of 2 / 10 to FRESHPET INC (FRPT). This can be considered as Overvalued.


How profitable is FRESHPET INC (FRPT) stock?

FRESHPET INC (FRPT) has a profitability rating of 4 / 10.


Can you provide the financial health for FRPT stock?

The financial health rating of FRESHPET INC (FRPT) is 6 / 10.


What is the earnings growth outlook for FRESHPET INC?

The Earnings per Share (EPS) of FRESHPET INC (FRPT) is expected to grow by 16.6% in the next year.